Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDA | P32320 | 5/20 | 0.40 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.40 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.40 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.40 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 6/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | MTOR | P42345 | 2/20 | 0.39 |
| ▸ | THPO | P40225 | 2/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.39 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.39 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | GMNN | O75496 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21357702 | 1.00 | CDA (0.40) | CDASLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL26668687 | 0.89 | LGALS8 (0.35) | CDA | |
| SCHEMBL8720503 | 0.87 | CDA (0.38) | CDASLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL9057982 | 0.85 | ADORA2A (0.37) | CDASLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL10903345 | 0.84 | CDA (0.42) | CDASLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL9368753 | 0.84 | TK2 (0.40) | CDALMNASMN1; SMN2ALDH1A1POLB | |
| SCHEMBL9057960 | 0.84 | SMN1; SMN2 (0.36) | CDASLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL6906558 | 0.84 | LMNA (0.45) | CDASLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL3630509 | 0.84 | LMNA (0.45) | CDASLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL27284021 | 0.83 | SLC28A1 (0.39) | CDASLC28A1SLC28A2SLC29A1SLC28A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3456 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4720279-A2 | CIS-REGULATORY ELEMENTS OF TRANSLATION AND METHODS USING SAME | Yale University (US) | 2026-04-08 | — | — | EP | claimed |
| EP-4716748-A2 | METHOD OF MODULATING MRNA TRANSLATION | Yale University (US) | 2026-04-01 | — | — | EP | claimed |
| EP-4705481-A2 | CIRCULAR RNA COMPOSITIONS AND METHODS | Orna Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| US-20250304965-A1 | DOUBLE-STRANDED RNA MOLECULE AND PHARMACEUTICAL USE THEREOF | MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2025-10-02 | — | — | US | claimed |
| US-20250188481-A1 | METHOD OF MODULATING MRNA TRANSLATION | UNIV YALE (US) | 2025-06-12 | — | — | US | claimed |
| CN-119252330-A | RNA N4-acetylcytidine modification site prediction method and system based on RNAErnie pre-training model | 海南大学 | 2025-01-03 | — | — | CN | claimed |
| WO-2024249370-A2 | CIS-REGULATORY ELEMENTS OF TRANSLATION AND METHODS USING SAME | YALE UNIVERSITY (US) | 2024-12-05 | — | — | WO | claimed |
| WO-2024243389-A2 | METHOD OF MODULATING MRNA TRANSLATION | YALE UNIVERSITY (US) | 2024-11-28 | — | — | WO | claimed |
| WO-2024233308-A2 | CIRCULAR RNA COMPOSITIONS AND METHODS | ORNA THERAPEUTICS, INC. (US) | 2024-11-14 | — | — | WO | claimed |
| CN-115487542-B | Solid phase extraction method of modified nucleoside in urine and application thereof | 浙江大学 | 2024-09-10 | — | — | CN | claimed |
| WO-2012065231-A1 | SIGNAL AMPLIFICATION | SPEEDX PTY LTD (AU) | 2012-05-24 | — | — | WO | claimed |
| US-20110172289-A1 | MINOR GROOVE BINDER (MGB)-OLIGONUCLEOTIDE MIRNA ANTAGONISTS | ELITECH HOLDING B.V. | 2011-07-14 | — | — | US | claimed |
| WO-2011066312-A1 | MINOR GROOVE BINDER (MGB)-OLIGONUCLEOTIDE MIRNA ANTAGONISTS | ELITECH HOLDING B.V. (NL) | 2011-06-03 | — | — | WO | claimed |
| CN-101341260-A | Multi-component nucleases and methods of use thereof | JOHNSON & JOHNSON RES PTY LTD (AU) | 2009-01-07 | — | — | CN | claimed |
| EP-1948822-A1 | MULTICOMPONENT NUCLEIC ACID ENZYMES AND METHODS FOR THEIR USE | JOHNSON & JOHNSON RESEARCH PTY LIMITED (AU) | 2008-07-30 | — | — | EP | claimed |
| US-20070231810-A1 | Multicomponent nucleic acid enzymes and methods for their use | SPEEDX PTY LTD (AU) | 2007-10-04 | — | — | US | claimed |
| WO-2007041774-A1 | MULTICOMPONENT NUCLEIC ACID ENZYMES AND METHODS FOR THEIR USE | JOHNSON & JOHNSON RESEARCH PTY LIMITED (AU) | 2007-04-19 | — | — | WO | claimed |
| US-6706691-B1 | BIOAVAILABILITY OF COMPOSITIONS METABOLIZED BY THE GUT P450 ISOZYMES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2004-03-16 | — | — | US | claimed |
| EP-0795029-A1 | CHEMICAL LABELLING OF OBJECTS | Pabio (NO) | 1997-09-17 | — | — | EP | claimed |
| WO-1996017954-A1 | CHEMICAL LABELLING OF OBJECTS | PABIO (DK) | 1996-06-13 | — | — | WO | claimed |